Almirall, S.A. ALM.MC
ES · Bolsa de Madrid · XMAD · stock · Healthcare · website
Almirall, S.A. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €1.1B | €985.7M | €894.5M | €863.2M |
| Gross profit | €871.6M | €767.7M | €682.0M | €662.5M |
| R&D expense | €96.0M | €79.0M | €66.9M | €64.3M |
| SG&A expense | €130.1M | €131.6M | €119.1M | €42.4M |
| Operating income | €66.8M | €46.8M | €41.2M | €68.8M |
| Interest expense | €8.4M | €8.2M | €7.2M | €7.4M |
| Income tax | €28.3M | €16.4M | €21.3M | €26.7M |
| Net income | €46.2M | €10.1M | -€38.5M | €4.3M |
| EPS (diluted) | €0.22 | €0.05 | €-0.17 | €0.02 |
| Operating cash flow | €174.5M | €160.8M | €93.5M | €155.1M |
| Free cash flow | €37.2M | -€664,000 | -€65.8M | €38.6M |
| Cash & equivalents | €337.8M | €377.1M | €388.0M | €248.8M |
| Inventory | €178.1M | €171.7M | €167.4M | €129.9M |
| Goodwill | €316.0M | €316.0M | €316.0M | €316.0M |
| Total assets | €2.3B | €2.4B | €2.4B | €2.1B |
| Total debt | €342.9M | €408.8M | €403.2M | €403.9M |
| Total liabilities | €850.0M | €908.3M | €911.6M | €829.0M |
| Shareholders' equity | €1.5B | €1.5B | €1.5B | €1.3B |
Growth · year-over-year · Revenue CAGR 8.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +12.4% | +10.2% | +3.6% | — |
| Net income growth | +354.9% | — | -998.7% | — |
| EPS growth | +340.0% | — | -1000.0% | — |
| Free cash flow growth | — | — | -270.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · ES · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.